Join us at the 2nd Allogeneic Cell Therapies Summit Europe 2023 in London, UK.
Topic: Risk mitigation strategies for critical raw materials in cell therapy manufacturing: addressing cryopreservation.
- Keeping an ATMP manufacturing workflow in a state of control entails risk assessing critical raw materials
- Cryopreservation is key to address multiple challenges in cell therapy manufacturing
- DMSO is commonly used as a cryoprotectant, but has risks that can be adressed by DMSO-free formulations
Presenter: Gonçalo Regalo, PhD, Strategic Business Development, Life Sciences, FUJIFILM Irvine Scientific